medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

<< Back Next >>

Rev Mex Urol 2018; 78 (2)

Bellini duct carcinoma: Medium-term recurrence

Rodríguez-Álvarez JS, Cruz-Ruiz J, Redding-Ochoa RJ, Gamboa-Domínguez A, Montante-Montes de Oca D, Rodríguez-Covarrubias F
Full text How to cite this article

Language: Spanish
References: 8
Page: 149-154
PDF size: 779.64 Kb.


Key words:

Collecting duct carcinoma, Recurrence, Survival.

ABSTRACT

Clinic case: A 77-year-old woman had clinical symptom onset with pain in the left flank of 20-day progression and bone pain. An ultrasound study identified an upper pole-dependent mass on the left kidney. A non-contrast-enhanced tomography scan, complemented with a magnetic resonance study, revealed a solid lesion with central necrosis that extended into the renal sinus (T2a; GII). Treatment was laparoscopic left radical nephrectomy. The diagnosis was Bellini duct carcinoma. A new 16-mm left lateroaortic lymph node was found at the follow-up at 5 months. The lesion was excised, and retroperitoneal lymph node dissection was carried out, producing 20 lymph nodes with lymphoid hyperplasia that were negative for malignancy. Thirtynine months after the nephrectomy, a computed tomography scan identified a retroperitoneal paraaortic tumor and an intercaval-aortic retroperitoneal tumor consistent with disease recurrence. Metastasectomy was performed and the histopathologic report described a solid, irregular, greyish-white tumor that had extensive hemorrhaging in the left lower portion and a moderate amount of necrotic foci. At present, after 42 months of follow-up, the patient is under surveillance and has no signs of recurrence.
Conclusions: Collecting duct carcinoma is a rare neoplasia. The case reported herein has the longest survival period and recurrence time presently described for symptomatic T2M0 disease: 39 months.


REFERENCES

  1. Yoon SK, Rha SH. Collecting duct carcinoma. En: Guermazi A, Editor. Imaging in kidney cancer. 1ª ed. Berlin: Springer- Verlag, 2003; 171-185.

  2. Sui W, Matulay JT, Robbins DJ, James MB, Onyeji IC, et al. Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. Urol Oncol 2017;35(9):540.e13-18.

  3. Ciszewski S, Jakimow A, Smolska-Ciszewska B. Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of literatura. Can Urol Assoc J 2015;9(9- 10):E589-93.

  4. Mishra AK, Manikandan R, Dorairajan LN, Mittal JK, Rekha JS. Bellini duct carcinoma: a rare entity J Clin Diag Res 2016;10(10):PD01-02.

  5. Dason S, Allard C, Sheridan-Jonah A, Gill J, Jamshaid H, et al. Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. Curr Oncol 2013;20:223-232.

  6. Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, et al. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol 2007;52:1140-5. doi: 10.1016/j.eururo.2007.01.070

  7. Husillos A, Herrans-Amo F, Subirá D, Lledó E, et al Collecting duct renal cell carcinoma Actas Urol Esp 2011;35:368-71.

  8. Rodríguez-Carlin JA, Vidal-Mora I, Arellano L, Castillo OA. Carcinoma renal de los conductos colectores de Bellini con recidiva retroperitoneal por otro tipo histológico de tumor renal. Arch Esp Urol 2013;66(6):597-1.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2018;78